COMPASS Pathways plc
For the period ended Dec 31, 2025. Filed Mar 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 24, 2026
CMPS$9.25+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ (Deficit)Equity
| ORDINARY SHARES · ADDITIONAL PAID-IN CAPITAL · ACCUMULATED OTHER COMPREHENSIVE (LOSS)/INCOME · ACCUMULATED DEFICIT · TOTAL SHAREHOLDERS' (DEFICIT)/EQUITY | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| £0.008 PAR VALUE | ||||||||||||
| SHARES · AMOUNT · AMOUNT · AMOUNT · AMOUNT · AMOUNT | ||||||||||||
| Balance at December 31, 2023 | 61,943,471 | $635 | 621,645 | $(16,926) | $(379,610) | $225,744 | ||||||
| Issuance of ordinary shares under ATM facility, net of issuance costs | 2,509,798 | 25 | 26,194 | — | — | 26,219 | ||||||
| Issuance of warrants to purchase ordinary shares | 3,752,050 | 38 | 37,220 | — | — | 37,258 | ||||||
| Exercise of share options | 189,214 | 2 | 219 | — | — | 221 | ||||||
| Issuance of ordinary shares to settle vested restricted stock units | 83,527 | 1 | (1) | — | — | — | ||||||
| Issuance of ordinary shares under employee share purchase plan | 74,155 | 1 | 364 | — | — | 365 | ||||||
| Shares tendered for withholding taxes | — | — | (239) | — | — | (239) | ||||||
| Share-based compensation expense | — | — | 19,517 | — | — | 19,517 | ||||||
| Unrealized gain on foreign currency translation | — | — | — | 732 | — | 732 | ||||||
| Net loss | — | — | — | — | (155,122) | (155,122) | ||||||
| Balance at December 31, 2024 | 68,552,215 | $702 | 704,919 | $(16,194) | $(534,732) | $154,695 | ||||||
| Issuance of ordinary shares, net of issuance costs | 24,014,728 | 233 | 54,584 | 54,817 | ||||||||
| Exercise of share options | 925,179 | 10 | 25 | — | — | — | — | — | 35 | |||
| Issuance of ordinary shares to settle vested restricted stock units | 156,245 | 2 | (1) | — | — | 1 | ||||||
| Issuance of ordinary shares under employee share purchase plan | 92,752 | 1 | 318 | 319 | ||||||||
| Issuance of ordinary shares to settle warrant exercised | 2,344,666 | 25 | 10,127 | — | — | 10,152 | ||||||
| Share-based compensation expense | — | — | 13,590 | — | — | 13,590 | ||||||
| Unrealized gain on foreign currency translation | — | — | — | 1,405 | — | 1,405 | ||||||
| Net loss | — | — | — | — | (287,862) | (287,862) | ||||||
| Balance at December 31, 2025 | 96,085,785 | $973 | 783,562 | $(14,789) | $(822,594) | $(52,848) | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.